Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis

被引:12
|
作者
Alosaimi, Fahad D. [1 ]
AlMulhem, Alaa [2 ]
AlShalan, Hanan [2 ]
Alqazlan, Mohammad [3 ]
Aldaif, Abdulgader [4 ]
Kowgier, Matthew [5 ]
Balasundaram, Janooshsheya [6 ]
Sockalingam, Sanjeev [6 ,7 ]
机构
[1] King Saud Univ, Dept Psychiat, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Riyadh, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Med Hlth, Riyadh, Saudi Arabia
[4] King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Univ Hlth Network, Ctr Mental Hlth, Toronto, ON, Canada
[7] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
来源
关键词
multiple sclerosis; adherence; depression; attachment style; culture; MORTALITY; SEVERITY; DEPRESSION; PREVALENCE; VALIDITY; CARE; TOOL;
D O I
10.2147/PPA.S129678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culturespecific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. Methods: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. Results: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%+/- 25.26%. Multivariate linear regression analysis only identified patients' belief that their MS was due to "supernatural" forces as being significantly negatively associated with MS medication adherence. Conclusion: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 50 条
  • [31] Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
    Washington, Francesca
    Langdon, Dawn
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 1861 - 1872
  • [32] The Impact of Adherence to Disease-Modifying Therapies on Functional Outcomes in Veterans with Multiple Sclerosis
    Rabadi, Meheroz H.
    Just, Kimberly
    Xu, Chao
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2021, 13
  • [33] Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records
    Mckay, Kyla A.
    Evans, Charity
    Fisk, John D.
    Patten, Scott B.
    Fiest, Kirsten
    Marrie, Ruth Ann
    Tremlett, Helen
    NEUROEPIDEMIOLOGY, 2017, 48 (3-4) : 124 - 130
  • [34] Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis
    Hincapie, Ana L.
    Penm, Jonathan
    Burns, Craig F.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (08): : 822 - 830
  • [35] Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
    Menzin, Joseph
    Caon, Christina
    Nichols, Christine
    White, Leigh Ann
    Friedman, Mark
    Pill, Michael W.
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : S24 - S40
  • [36] Adherence to disease-modifying therapies in multiple sclerosis: Does caregiver social support matter?
    Siegel, Scott D.
    Turner, Aaron P.
    Haselkorn, Jodie K.
    REHABILITATION PSYCHOLOGY, 2008, 53 (01) : 73 - 79
  • [37] Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
    Lee, Chi-Yan
    Chan, Koon-Ho
    PHARMACEUTICS, 2024, 16 (01)
  • [38] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Daniel M. Hartung
    Current Neurology and Neuroscience Reports, 2021, 21
  • [39] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
  • [40] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Hartung, Daniel M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)